The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

7551–7575 of 11823

  • SevereFDA (Drugs)·D-1181-2016·2016-07-20

    Medaus Recalls DMSO 99.9 Vials Due to Sterility Concerns

    Medaus, Inc. is recalling DMSO 99.9 vials because the company cannot ensure the product is sterile. The recall covers 5 mL and 10 mL vials distributed in the U.S., Japan, and New Zealand.

    Product
    DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1343-2016·2016-07-20

    Pharmakon Recalls Bupivacaine Bags Due to Sterility Concerns

    Pharmakon Pharmaceuticals is recalling 70 units of Bupivacaine HCI 0.25% bags because the company cannot assure the products are sterile.

    Product
    Bupivacaine HCI 0.25% in 0.9% Sodium Chloride, 500 mL Intravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0994-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1284-2016·2016-07-20

    Pharmakon Recalls Hydromorphone Cadd Cassettes Due to Sterility Concerns

    Pharmakon Pharmaceuticals is recalling 10 units of Hydromorphone HCI cadd cassettes because the company cannot guarantee the products are sterile.

    Product
    Hydromorphone HCI 0.2mg/mL in 0.9% Sodium Chloride 50 mL Cadd Cassette (grey), Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0504-41
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1183-2016·2016-07-20

    Medaus Recalls Estradiolval and Testosterone Vials Due to Sterility Concerns

    Medaus, Inc. is recalling Estradiolval and testosterone vials because the company cannot ensure the product is sterile.

    Product
    ESTRADIOLVAL 3MG/TEST CYP 35MG/ TEST PROP 35MG/ML W/PRES. (BENZYL ETOH 2%), 3ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1280-2016·2016-07-20

    Pharmakon Recalls Cefazolin Sodium Chloride Bags Due to Sterility Concerns

    Pharmakon Pharmaceuticals is recalling 18 units of Cefazolin 3GM in 0.9% Sodium Chloride bags due to a lack of assurance of sterility.

    Product
    Cefazolin 3GM Added to a 100 mL 0.9% Sodium Chloride Bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0223-48
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1225-2016·2016-07-20

    Medaus Recalls M.I.C 25/50/50 Vials Due to Sterility Concerns

    Medaus, Inc. is recalling M.I.C 25/50/50 vials because the product lacks assurance of sterility. The recall affects 2,000 mL in vials distributed in the U.S., Japan, and New Zealand.

    Product
    M.I.C 25/50/50 W/METHYL B12 1MG/PYRIDOXAL 50MG/ML (PF), 1ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1349-2016·2016-07-20

    FDA Recalls Crocodile Bile Pills Marketed as Unapproved Asthma Drug

    Murray International Trading Co. is recalling Crocodile Bile Pills for Asthma because they are marketed as dietary supplements but contain drug claims, making them unapproved drugs.

    Product
    CROCODILE BILE PILL FOR ASTHMA, packaged in 100-count bottles within a box, remaining labeling contains Chinese characters.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1264-2016·2016-07-20

    Pharmakon Recalls Propofol Injection Due to Sterility Concerns

    Pharmakon Pharmaceuticals is recalling 2,580 units of compounded Propofol 1% injection because the company cannot ensure the product is sterile.

    Product
    Propofol1% 10mg/mL injection, 20 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0119-73
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1329-2016·2016-07-20

    Pharmakon Recalls Ketamine Syringes Due to Sterility Concerns

    Pharmakon Pharmaceuticals is recalling 150 units of compounded Ketamine 2 mg/mL syringes due to a lack of assurance of sterility. The products were distributed nationwide and to specific VA/DOD facilities.

    Product
    Ketamine 2 mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0938-68
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1292-2016·2016-07-20

    Pharmakon Recalls Hydromorphone Syringes Due to Sterility Concerns

    Pharmakon Pharmaceuticals is recalling 20 units of compounded Hydromorphone HCI syringes due to a lack of assurance of sterility.

    Product
    Hydromorphone HCI 0.4mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0684-68
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1167-2016·2016-07-20

    Medaus Recalls B-Complex #3 Vials Due to Sterility Concerns

    Medaus, Inc. is recalling B-Complex #3 vials because the company cannot ensure the product is sterile. The recall covers vials distributed in the U.S., Japan, and New Zealand.

    Product
    B-COMPLEX #3 (PF), B1-100MG, B2-2-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 2ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1172-2016·2016-07-20

    Medaus Recalls B-Complex 50 Vials Due to Sterility Concerns

    Medaus, Inc. is recalling B-Complex 50 in NaCl 0.9% vials because the company cannot assure the sterility of the product.

    Product
    B-COMPLEX 50 IN NACL 0.9% (PF) B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 2ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1250-2016·2016-07-20

    Medaus Recalls Zinc Chloride Vials Due to Sterility Concerns

    Medaus, Inc. is recalling specific lots of Zinc Chloride vials because the company cannot guarantee the product is sterile.

    Product
    ZINC CHLORIDE 10MG/ML IN NACL 0.29% (PF), 2ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1196-2016·2016-07-20

    Medaus Recalls L-Carnitine Vials Due to Sterility Concerns

    Medaus, Inc. is recalling specific lots of L-Carnitine 250mg/mL vials because the company cannot guarantee the product is sterile.

    Product
    L-CARNITINE 250MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1228-2016·2016-07-20

    Medaus Recalls Sodium Ascorbate Vials Due to Sterility Concerns

    Medaus, Inc. is recalling specific lots of Sodium Ascorbate 500mg/mL vials because the company cannot ensure the product is sterile.

    Product
    NA ASCORBATE 500MG/ML (PF), In a) 10ML Vials, b) 50ML Vials, and c) 100ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1219-2016·2016-07-20

    Medaus Recalls Methyl B12 Vials Due to Sterility Concerns

    Medaus, Inc. is recalling specific lots of Methyl B12 10mg/mL vials because the company cannot guarantee the product is sterile.

    Product
    METHYL B12 10MG/ML W/PRES (BENZALKONIUM 0.01%) IN NACL 0.9%, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1214-2016·2016-07-20

    Medaus Recalls Methyl B12 Vials Due to Sterility Assurance Concerns

    Medaus, Inc. is recalling Methyl B12 1000mcg/mL vials distributed in the U.S., Japan, and New Zealand due to a lack of assurance of sterility.

    Product
    METHYL B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01% IN NACL 0.9%, In a) 2ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1141-2016·2016-07-13

    Bee Extremely Amazed LLC Recalls Infinity Capsules Tainted With Sibutramine

    Bee Extremely Amazed LLC is recalling Infinity Capsules because the product was found to contain undeclared sibutramine, a withdrawn appetite suppressant.

    Product
    Infinity Capsules, 500 mg, 30-count bottle, Manufactured for Floyd Nutrition
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1149-2016·2016-07-13

    XCEL Capsules Recalled for Undeclared Fluoxetine and Phenolphthalein

    Bee Extremely Amazed LLC is recalling XCEL Capsules marketed as a dietary supplement because they contain undeclared fluoxetine and phenolphthalein.

    Product
    XCEL Capsules, 300 mg, 60-count bottles, Manufactured for JNS Health
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1151-2016·2016-07-13

    ZI XIU TANG Beauty Capsules Recalled for Undeclared Sibutramine

    Bee Extremely Amazed LLC is recalling ZI XIU TANG Beauty Face & Figure Capsules because they contain undeclared sibutramine, a withdrawn drug.

    Product
    ZI XIU TANG BEAUTY FACE & FIGURE Capsules, 250 mg, 60-count bottles
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1144-2016·2016-07-13

    Oasis Capsules Recalled for Undeclared Sibutramine and Phenolphthalein

    Bee Extremely Amazed LLC is recalling Oasis Capsules because they contain undeclared sibutramine and phenolphthalein, making them unapproved drugs.

    Product
    Oasis Capsules, 500mg, 45-count bottles, Manufactured for: MWN Health 37 N Orange Ave Suite 500 Orlando FL 32801 (407)930-4043
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1139-2016·2016-07-13

    Asset extreme+PLUS Capsules Recalled for Undeclared Sibutramine

    Bee Extremely Amazed LLC is recalling Asset extreme+PLUS Capsules because the product was found to contain undeclared sibutramine, a withdrawn appetite suppressant.

    Product
    Asset extreme+PLUS Capsules, 500 mg, 30-count bottles, Distributed by Descor, LLC www.assetcapsules4u.com www.allnaturalbeelievers.com
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1150-2016·2016-07-13

    XCEL Advanced Capsules Recalled for Undeclared Phenolphthalein

    Bee Extremely Amazed LLC is recalling XCEL Advanced Capsules because they contain undeclared phenolphthalein, a withdrawn ingredient with carcinogenic concerns.

    Product
    XCEL ADVANCED Capsules, 350mg, 60-count bottles, Manufactured for JNS Health
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1142-2016·2016-07-13

    Jenesis Capsules Recalled for Undeclared Sibutramine and Phenolphthalein

    Bee Extremely Amazed LLC is recalling Jenesis Capsules marketed as a dietary supplement because they contain undeclared sibutramine and phenolphthalein, both withdrawn from the US market for safety reasons.

    Product
    Jenesis Capsules, 350 mg, 60-count bottles, Manufactured for Timeless Solutions 1810 E. Sahara Ave #100 Las Vegas, Nevada 89104
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1137-2016·2016-07-13

    Hospira Recalls Magnesium Sulfate Injection Due to Particulate Matter

    Hospira Inc. is recalling specific lots of Magnesium Sulfate Injection due to confirmed particulate matter. The recall covers 88,500 vials distributed in the US and several Middle Eastern countries.

    Product
    Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.
    Category
    Drug
    Distribution
    Distributed nationwide